|
Nephrology
Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic
Ah-Young Kim, Min-Jeong Lee, Heejung Choi, Hankil Lee, Inwhee Park
Korean J Intern Med. 2024;39(6):967-978. Published online October 24, 2024
Background/Aims: The corona virus disease 2019 posed a major risk for end-stage kidney disease (ESKD) cases. Our study aimed to assess changes in kidney replacement therapy (KRT) trends and healthcare access for these patients during the pandemic.
Methods: We retrospectively analyzed nationwide dat..
|
|
|
A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness
Jie Liu, Shuang Li, Fan Yang, Tianyu Li, Rui Li, Yousuf Waheed, Chen Meng, Shulin Li, Kun Liu, Yanshan Tong, Haisheng Xu, Chuankuo Tian, Xinglei Zhou
Korean J Intern Med. 2024;39(3):488-500. Published online April 23, 2024
Background/Aims: Roxadustat, an oral medication for treating renal anemia, is a hypoxia-inducible factor prolyl hydroxylase inhibitor used for regulating iron metabolism and promoting erythropoiesis. To investigate the efficacy and safety of roxadustat in patients undergoing peritoneal dialysis (PD)..
|
|
|
The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study
Hyung Jong Kim, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Hyeong-Cheon Park, Shin-Wook Kang, Kyoung Hoon Kim, Dong-Ryeol Ryu, Hyunwook Kim
Korean J Intern Med. 2017;32(4):699-710. Published online June 26, 2017
Background/Aims: Since comorbidities are major determinants of modality choice, and also interact with dialysis modality on mortality outcomes, we examined the pattern of modality choice according to comorbidities and then evaluated how such choices affected mortality in incident dialysis patients.
..
|
|
|
Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
Ae Jin Kim, Hye Jin Lim, Han Ro, Ji Yong Jung, Hyun Hee Lee, Wookyung Chung, Jae Hyun Chang
Korean J Intern Med. 2016;31(4):730-738. Published online March 26, 2016
Background/Aims: Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mor..
|
|
|
Tumor necrosis factor α is a risk factor for infection in peritoneal dialysis patients
Eunjung Kang, Seihran Kim, Hwa Jung Lee, Inhwee Park, Heungsoo Kim, Gyu-Tae Shin
Korean J Intern Med. 2016;31(4):722-729. Published online March 22, 2016
Background/Aims: It has been shown that circulating tumor necrosis factor α (TNF-α) is elevated in end stage renal disease patients; however, the relationship between TNF-α and the development of infection in these patients is unknown. In this study, we investigated the association of plasma TNF-..
|
|
|
Impact of dialysis modality on technique survival in end-stage renal disease patients
Jong-Hak Lee, Sun-Hee Park, Jeong-Hoon Lim, Young-Jae Park, Sang Un Kim, Kyung-Hee Lee, Kyung-Hoon Kim, Seung Chan Park, Hee-Yeon Jung, Owen Kwon, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim
Korean J Intern Med. 2016;31(1):106-115. Published online December 28, 2015
Background/Aims: This study analyzed the risk factors for technique survival in dialysis patients and compared technique survival rates between hemodialysis (HD) and peritoneal dialysis (PD) in a prospective cohort of Korean patients.
Methods: A total of 1,042 patients undergoing dialysis from Sept..
|
|
|
Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry
Dong Chan Jin
Korean J Intern Med. 2015;30(1):17-22. Published online December 30, 2014
The Korean Society of Nephrology (KSN) launched a nationwide end-stage renal disease (ESRD) patient registry in 1985 called the Insan Prof. Byung-Suk Min Memorial ESRD Patient Registry. KSN members voluntarily participate in this registry, which has been collecting data through the Internet since 20..
|
|
|
Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients
Soon Mi Hur, Hye Young Ju, Moo Yong Park, Soo Jeong Choi, Jin Kuk Kim, Seung Duk Hwang
Korean J Intern Med. 2014;29(4):489-497. Published online June 27, 2014
Background/Aims: Inflammation is an important factor in renal injury. Ferritin, an inflammatory marker, is considered an independent predictor of rapid renal progression in patients with chronic kidney disease. However, the relationship between ferritin and residual renal function (RRF) in patients ..
|
|
|
Encapsulating peritoneal sclerosis: case series from a university center
Kyung-Deuk Hong, Ji Hea Bae, Yun-Jin Jang, Hee-Yeon Jung, Jang-Hee Cho, Ji-Young Choi, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park
Korean J Intern Med. 2013;28(5):587-593. Published online August 14, 2013
Background/AimsEncapsulating peritoneal sclerosis (EPS) is an often-fatal complication of long-term peritoneal dialysis (PD). We here report the clinical features of EPS in Korean PD patients from a single university center. MethodsThe data were..
|
|
|
Current Status of Dialysis Therapy in Korea
Dong Chan Jin
Korean J Intern Med. 2011;26(2):123-131. Published online June 1, 2011
The number of patients with end-stage renal disease (ESRD) is rising very rapidly as the number of elderly and patients with diabetes increases in Korea. ESRD Registry Committee of the Korean Society of Nephrology (KSN) collected dialysis therapy data in Korea through an online registry program o..
|
|
|
Comparison of Clinical Outcomes by Different Renal Replacement Therapy in Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
Seok-Hui Kang, Byung-Ha Chung, Sun-Ryoung Choi, Ja-Young Lee, Hoon-Suk Park, In-O Sun, Bum-Soon Choi, Cheol-Whee Park, Yong-Soo Kim, Chul-Woo Yang
Korean J Intern Med. 2011;26(1):60-67. Published online March 2, 2011
Background/AimsMany studies have compared patients with systemic lupus erythematosus (SLE) on renal replacement therapy (RRT) with non-lupus patients. However, few data are available on the long-term outcome of patients with end-stage renal disease (ESRD) secondary to SLE who ..
|
|
|
Detecting Bacterial Growth in Continuous Ambulatory Peritoneal Dialysis Effluent Using Two Culture Methods
Se-Hee Yoon, Nak Won Choi, Sung-Ro Yun
Korean J Intern Med. 2010;25(1):82-85. Published online February 26, 2010
Background/AimsThe aim of this study was to evaluate the peritonitis-causing bacteria detected in peritoneal fluid using a blood culture bottle in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). MethodsOne-hundred and eleve..
|
|
|
Hepatic Subcapsular Steatosis in a Diabetic CAPD Patient Receiving Intraperitoneal Insulin
Eun Chul Jang, Guilsun Kim, Young Soo Kim, Sun Ae Yoon, Young Mi Ku, Chul Woo Yang, Young Ok Kim
Korean J Intern Med. 2006;21(3):206-209. Published online September 30, 2006
Hepatic subcapsular steatosis is a rare and specific form of fatty change in the liver. It is a unique finding in diabetic patients receiving continuous ambulatory peritoneal dialysis (CAPD) and intraperitoneal insulin treatment. Intraperitoneal administration of insulin causes a unique pattern o..
|
|
|
Treadmill exercise-induced E/e’ elevation as a predictor of cardiovascular event in end-stage
renal disease on peritoneal dialysis
Jong Ho Shin, Ki-Woon Kang, Jung Ho Kim, Jung Yeon Chin, Nae Yu Kim, Sang Hyun Park, Won Ho Kim, Yu Jeong Choi, Kyung Tae Jung
Received April 13, 2016 Accepted May 13, 2016 Published online November 11, 2016
Background/Aims: Diastolic dysfunction is associated with cardiovascular (CV) events in end-stage renal disease (ESRD) on continuous ambulatory peritoneal dialysis (CAPD). However, conventional measurement of LA volume and E/e’ using Doppler echocardiography has been limited to predict CV events i..
|
|
|
